TrialNature medicine2025
Sacituzumab tirumotecan in previously treated metastatic triple-negative breast cancer: a randomized phase 3 trial.
Yongmei Yin et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
44 papers cite it
this paperpooled ittrialcites it